Neurocrine: Q3 Earnings Snapshot
By AP News
Published - Oct 30, 2024, 07:07 AM ET
Last Updated - Oct 30, 2024, 07:07 AM EDT
SAN DIEGO (AP) — SAN DIEGO (AP) — Neurocrine Biosciences Inc. (NBIX) on Wednesday reported third-quarter profit of $129.8 million.
The San Diego-based company said it had net income of $1.24 per share.
The results did not meet Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.47 per share.
The biopharmaceutical company posted revenue of $622.1 million in the period, which topped Street forecasts. Eleven analysts surveyed by Zacks expected $604.1 million.
